A61N1/0492

Structural integration and enhanced control of functional electrical stimulation in an exoskeleton device

An integrated functional electrical stimulation (FES) system includes a component of a mobility assistance device, and an FES system mounted within the component. The FES system includes an FES stimulator that is embedded within the component, and a plurality of FES jacks that are electrically connected to the FES stimulator and are located on the component. The FES jacks are configured to receive a plurality of FES electrodes, and an electrical stimulation output from the FES stimulator is conducted through the FES jacks to the FES electrodes. In a wireless embodiment, the FES stimulator is configured to wirelessly transmit a control signal for applying an electrical stimulation output to the plurality of FES electrodes, and the FES jacks are eliminated. The FES stimulator may be embedded within a back portion of the hip component of an exoskeleton device, and in the wired embodiment the FES jacks are located on wing portions of the hip component.

NERVE STIMULATION THERAPY FOR MAINTAINING TELOMERE LENGTHS
20220323745 · 2022-10-13 ·

Systems, devices and methods are provided for delivering electrical impulses to the vagus nerve to inhibit the reduction of telomere lengths in cellular DNA, thereby potentially increasing an individual's longevity and/or healthspan. A method comprises positioning a contact surface of a device in contact with an outer skin surface of a patient. An electrical impulse is applied transcutaneously from the device through the outer skin surface of the patient to a vagus nerve in the patient according to a stimulation protocol. The stimulation protocol includes at least two doses administered each day for a plurality of day. The doses each have a duration of about 60 seconds to about 5 minutes, preferably about 90 seconds to 3 minutes. The electrical impulse and the stimulation protocol are sufficient to modulate the vagus nerve such that such that the rate of telomere shortening in the patient's cellular DNA is reduced.

METHOD, DEVICE AND SYSTEM FOR WIRELESS BIOPOTENTIAL MEASUREMENT
20230112011 · 2023-04-13 ·

A system, method and sensor device for providing an Electrocardiogram (ECG) and arrhythmia analysis. The sensor device being adapted for attaching to the body, the sensor unit comprising: a reusable electronic device comprising a signal processor and transmitter part, and a patch including at least one measuring electrode for measuring a biopotential.

COMPOSITIONS AND METHODS FOR TESTING ADVERSE SKIN EVENTS
20230116844 · 2023-04-13 ·

Disclosed are apparatuses comprising at least one electrode element having a skin-facing surface; a skin contact layer comprising an adhesive composite, and an adhesive tape or bandage. Disclosed are methods comprising positioning one or more electrode assemblies on a target site of a subject, the one or more electrode assemblies comprising at least one electrode element having a skin-facing surface; a skin contact layer comprising a conductive adhesive composite, and an adhesive tape or bandage, wherein the at least one electrode element is electrically coupled to the skin contact layer. In some aspects, the methods further comprise removing at least one of the one or more electrode assemblies from the target site of the subject after a period of time. In some aspects, after removal of the one or more electrode assemblies, the target site is evaluated for an adverse event.

Systems and methods for physiological signal collection

A compact integrated patch may be used to collect physiological data. The patch may be wireless. The patch may be utilized in everyday life as well as in clinical environments. Data acquired by the patch and/or external devices may be interpreted and/or be utilized by healthcare professionals and/or computer algorithms (e.g., third party applications). Data acquired by the patch may be interpreted and be presented for viewing to healthcare professionals and/or ordinary users.

Systems and methods for treatment of a patient including rf and electrical energy

Systems and methods for a soft tissue treatment of a patient are provided herein. The device for a soft tissue treatment may include an applicator having at least one electrode, a fastening mechanism to fix the applicator to a body part of the patient, and a control unit having a microprocessor to control the at least one electrode. The at least one electrode may provide radiofrequency energy and pulsed electric current. The radiofrequency energy may cause a heating of a soft tissue. The electric current may cause contraction of a muscle within the body part. The body part may be a face.

STRUCTURAL INTEGRATION AND ENHANCED CONTROL OF FUNCTIONAL ELECTRICAL STIMULATION IN AN EXOSKELETON DEVICE

An integrated functional electrical stimulation (FES) system includes a component of a mobility assistance device, and an FES system mounted within the component. The FES system includes an FES stimulator that is embedded within the component, and a plurality of FES jacks that are electrically connected to the FES stimulator and are located on the component. The FES jacks are configured to receive a plurality of FES electrodes, and an electrical stimulation output from the FES stimulator is conducted through the FES jacks to the FES electrodes. In a wireless embodiment, the FES stimulator is configured to wirelessly transmit a control signal for applying an electrical stimulation output to the plurality of FES electrodes, and the FES jacks are eliminated. The FES stimulator may be embedded within a back portion of the hip component of an exoskeleton device, and in the wired embodiment the FES jacks are located on wing portions of the hip component.

Cage assembly for animal test subjects

A cage assembly can have at least one enclosure. Each enclosure can have a floor defining a floor area having a major dimension and a cover having a bottom surface. A spacing between the bottom surface of the cover and the floor can define a cage height. At least one sidewall can extend between the floor and the cover. A ratio of the cage height to the major dimension of the floor area of each enclosure of the at least one enclosure can be at least 0.70.

EXTERNAL TRIGEMINAL NERVE STIMULATION FOR THE ACUTE NON-INVASIVE TREATMENT OF MIGRAINE ATTACKS
20230108691 · 2023-04-06 ·

The current invention concerns a system and a method for the acute non-invasive treatment of a migraine attack. The system comprises at least one skin electrode for placement on the forehead of a patient. The system is configured for providing consecutive biphasic electrical pulses via said at least one skin electrode to the supratrochlear and supraorbital nerves of the ophthalmic branch of the trigeminal nerve during a prolonged time span. Preferably, the time span is at least 10 minutes.

SKIN PATCH FOR RF ENERGY-BASED TREATMENT DEVICE, A RF ENERGY-BASED TREATMENT DEVICE USING SAME, A METHOD OF CONTROLLING THE SAME, AND A RF ENERGY-BASED SKIN TREATMENT METHOD
20220313988 · 2022-10-06 ·

The present invention relates to: a skin patch for an RF energy-using treatment device, the skin patch which has one surface in contact with the skin and has the other surface that is usable by making contact with an electrode of the RF energy-using treatment device, and which comprises a marker so as to guide treatment of the RF energy-using treatment device; an RF energy using treatment device using the skin patch; a control method therefor; and an RF energy-using skin treatment method. The skin patch for an RF energy-using treatment device, the RF energy-using treatment device using same, the control method therefor and the RF energy-using skin treatment method, according to the present invention, can guide the treatment location of a user from the patch attached to the skin, and control RF energy so as to improve treatment precision.